These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11332437)

  • 1. Osteoporosis and androgen-depleting drugs in sex offenders.
    Gooren LJ; Lips P; Gijs L
    Lancet; 2001 Apr; 357(9263):1208-9. PubMed ID: 11332437
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk/benefit ratio of androgen deprivation treatment for sex offenders.
    Berlin FS
    J Am Acad Psychiatry Law; 2009; 37(1):59-62. PubMed ID: 19297635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential side effects of androgen deprivation treatment in sex offenders.
    Giltay EJ; Gooren LJ
    J Am Acad Psychiatry Law; 2009; 37(1):53-8. PubMed ID: 19297634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical review: Ethical and medical considerations of androgen deprivation treatment of sex offenders.
    Gooren LJ
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3628-37. PubMed ID: 21956411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Osteoporosis due to androgen suppression therapy in men with prostate cancer].
    Roux C
    Prog Urol; 2003 Apr; 13(2 Suppl 1):24-7. PubMed ID: 12815806
    [No Abstract]   [Full Text] [Related]  

  • 6. [Osteoporosis in castration therapy--a neglected field].
    Bratt O; Akesson K
    Lakartidningen; 2011 Sep 28-Oct 4; 108(39):1902-5. PubMed ID: 22111227
    [No Abstract]   [Full Text] [Related]  

  • 7. Osteoporosis during androgen deprivation therapy for prostate cancer.
    Smith MR
    Urology; 2002 Sep; 60(3 Suppl 1):79-85; discussion 86. PubMed ID: 12231056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gonadorelin analogs combined with anti-androgens in the treatment of bone metastasis from prostate cancer. Can their use induce osteoporosis?].
    Simonin R; Nicolino-Peltier C; Gainlet P
    Presse Med; 1989 Dec; 18(41):2023. PubMed ID: 2532342
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate cancer, osteoporosis and fracture risk.
    Allain TJ
    Gerontology; 2006; 52(2):107-10. PubMed ID: 16508318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male osteoporosis associated with longterm cyproterone treatment.
    Vasireddy S; Swinson DR
    J Rheumatol; 2001 Jul; 28(7):1702-3. PubMed ID: 11469484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone loss in men under androgen-deprivation therapy for prostate cancer].
    Ishizaka K; Machida T; Yoshida K
    Nihon Rinsho; 2005 Apr; 63(4):721-6. PubMed ID: 15828242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis and antiandrogens. An under-recognised risk.
    Sherriff JM; Brown JE; James ND
    BMJ; 2010 Jan; 340():c143. PubMed ID: 20071430
    [No Abstract]   [Full Text] [Related]  

  • 13. [Osteoporosis prophylaxis in men? Adverse effects of total androgen blockade in carcinoma of the prostate].
    Hüfner M
    Internist (Berl); 1999 Aug; 40(8):883. PubMed ID: 10476490
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for osteoporosis in men receiving androgen deprivation therapy.
    Alibhai SM; Yun L; Cheung AM; Paszat L
    JAMA; 2012 Jan; 307(3):255-6. PubMed ID: 22253389
    [No Abstract]   [Full Text] [Related]  

  • 15. Osteoporosis from androgen deprivation therapy in prostate cancer treatment.
    McLeod N; Huynh CC; Rashid P
    Aust Fam Physician; 2006 Apr; 35(4):243-5. PubMed ID: 16642243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials test bisphosphonates in hormone-sensitive prostate cancer.
    Bankhead C
    J Natl Cancer Inst; 2003 Sep; 95(17):1273-4. PubMed ID: 12953081
    [No Abstract]   [Full Text] [Related]  

  • 17. [Osteoporosis fracture in a male patient secondary to hypogonadism due to androgen deprivation treatment for prostate cancer].
    Verdú Solans J; Roig Grau I; Almirall Banqué C
    Semergen; 2014; 40(4):e73-6. PubMed ID: 23768568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostate cancer and androgen deprivation: benefits of psychological counseling].
    Frambati L; Weber K; Canuto A; Miralbell R; Zilli T; Pichard C; Joly C; Voison N; Santos JF
    Rev Med Suisse; 2013 Feb; 9(373):369-70, 372-3. PubMed ID: 23477070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low rate of bone density testing in men receiving androgen deprivation therapy.
    Barton MK
    CA Cancer J Clin; 2013; 63(2):85-6. PubMed ID: 23319451
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen deprivation therapy.
    Bhoopalam N; Campbell SC; Moritz T; Broderick WR; Iyer P; Arcenas AG; Van Veldhuizen PJ; Friedman N; Reda D; Warren S; Garewal H
    J Urol; 2009 Nov; 182(5):2257-64. PubMed ID: 19758618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.